IND cleared for the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe psoriasis, with initial data expected 2H 2026 Interim…
Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar…
The agreement with BNW Real Estate Development LLC positions NewGenDigital to maximize the profitability of its recently acquired plot of…
Executive Chairman & CEO of the Company to Participate in a Fireside ChatPhiladelphia, Pennsylvania--(Newsfile Corp. - July 21, 2025) -…
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce the appointment of…
Huntersville, Ontario--(Newsfile Corp. - July 21, 2025) - As Canada's premiers gather for the Council of the Federation (COF) Summer…
STOCKHOLM, July 21, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that AKSM/Oncology has selected RayCare®* oncology information…
Phoenix platform matches users with genetically similar people to predict which interventions actually work. SINGAPORE, July 18, 2025 (GLOBE NEWSWIRE)…
DAYTON, Ohio, July 18, 2025 /PRNewswire/ -- Premier Health Partners ("Premier Health") is providing notice of a cyber incident that…
Partnership with Louis Hernandez Jr, For A Bright Future Foundation, has a long history of supporting equal access to healthcare…